Literature DB >> 19602555

Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency.

Hershel Raff1.   

Abstract

CONTEXT: The measurement of cortisol in saliva is a simple, reproducible, and reliable test to evaluate the normal and disordered control of the hypothalamic-pituitary-adrenal (HPA) axis. There are a variety of simple methods to obtain saliva samples without stress, making this a robust test applicable to many different experimental and clinical situations. EVIDENCE ACQUISITION: Ovid Medline and PubMed from 1950 to present were searched using the following strategies: [<saliva or salivary>and<cortisol or hydrocortisone>and<Cushing or Cushing's>] and [<saliva or salivary>and<cortisol or hydrocortisone>and<adrenal insufficiency or hypoadrenalism or hypopituitarism or Addison's disease>]. The bibliographies of all relevant citations were evaluated for any additional appropriate citations. EVIDENCE SYNTHESIS: Measurement of an elevated late-night (2300 to 2400 h) salivary cortisol has a greater than 90% sensitivity and specificity for the diagnosis of endogenous Cushing's syndrome. Late-night salivary cortisol measurements are also useful to monitor patients for remission and/or recurrence after pituitary surgery for Cushing's disease. Because it is a surrogate for plasma free cortisol, the measurement of salivary cortisol may be useful during an ACTH stimulation test in patients with increased plasma binding protein concentrations due to increased estrogen, or decreased plasma binding protein concentrations during critical illness. Most reference laboratories now offer salivary cortisol testing.
CONCLUSIONS: It is expected that the use of the measurement of salivary cortisol will become routine in the evaluation of patients with disorders of the HPA axis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602555     DOI: 10.1210/jc.2009-1166

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  Diurnal variation of cortisol in people with dementia: relationship to cognition and illness burden.

Authors:  Christine R Kovach; Diana Lynn Woods; Brent R Logan; Hershel Raff
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-01-27       Impact factor: 2.035

2.  Salivary cortisol in obstructive sleep apnea: the effect of CPAP.

Authors:  Hershel Raff; Sandra L Ettema; Daniel C Eastwood; B Tucker Woodson
Journal:  Endocrine       Date:  2011-04-26       Impact factor: 3.633

3.  Salivary cortisol and the diagnosis of Cushing's syndrome: a coming of age.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2012-06       Impact factor: 3.633

4.  Biomarkers: Salivary cortisol or cortisone?

Authors:  Hershel Raff; James W Findling
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

Review 5.  Cushing's syndrome: diagnosis and surveillance using salivary cortisol.

Authors:  Hershel Raff
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 6.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

Review 7.  Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies.

Authors:  Sherita Hill Golden; Gary S Wand; Saurabh Malhotra; Ihab Kamel; Karen Horton
Journal:  Eur J Epidemiol       Date:  2011-04-30       Impact factor: 8.082

8.  Management of hypogonadism: is there a role for salivary testosterone.

Authors:  Tom Fiers; Jean-Marc Kaufman
Journal:  Endocrine       Date:  2015-06-11       Impact factor: 3.633

Review 9.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 10.  Cushing's syndrome: from physiological principles to diagnosis and clinical care.

Authors:  Hershel Raff; Ty Carroll
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.